Jennifer A Simpson

US Patent:

20190282398, Sep 19, 2019

Filed:

Mar 5, 2019

Appl. No.:

16/293220

Inventors:

- Houston TX, US
- Oakland CA, US
Cintia S. De Paiva - Houston TX, US
Jennifer L. Simpson - Irvine CA, US

International Classification:

A61F 9/00
B29C 33/38
A61K 9/00
B29C 39/02

Abstract:

A therapeutics delivery system, and methods of making and using same, are disclosed for environments that rapidly clear any injected therapeutics, such as a patient's eye. The therapeutics delivery system releases the drug in a therapeutically effective concentration for a desired duration of time with a predefined drug kinetics. In one embodiment, the embodiments of the present disclosure release a therapeutically effective concentration for a longer time period than other delivery systems, for instance from a day to a week. Certain embodiments comprise a therapeutics dispensing device comprising a biodissolvable hydrogel matrix for long term drug release that allows the device to be placed directly at the injured site, e.g., onto the surface at or near the injury, and retained there rather than through injection, whether locally or systematically.

US Patent:

20150190279, Jul 9, 2015

Filed:

Aug 6, 2013

Appl. No.:

14/420295

Inventors:

- Houston TX, US
- Oakland CA, US
Cintia S. De Paiva - Houston TX, US
Jennifer L. Simpson - Irvine CA, US

Assignee:

Baylor College of Medicine - Houston TX

International Classification:

A61F 9/00
B29C 33/38
B29C 39/02

Abstract:

A therapeutics delivery system, and methods of making and using same, are disclosed for environments that rapidly clear any injected therapeutics, such as a patient's eye. The therapeutics delivery system releases the drug in a therapeutically effective concentration for a desired duration of time with a predefined drug kinetics. In one embodiment, the embodiments of the present disclosure release a therapeutically effective concentration for a longer time period than other delivery systems, for instance from a day to a week. Certain embodiments comprise a therapeutics dispensing device comprising a biodissolvable hydrogel matrix for long term drug release that allows the device to be placed directly at the injured site, e.g., onto the surface at or near the injury, and retained there rather than through injection, whether locally or systematically.